• Going green Next Generation Pharmaceutical (Europe)             • Collaboration and innovation Next Generation Pharmaceutical (Europe)             • Pushing the frontiers of disease prevention Next Generation Pharmaceutical (Europe)             • The power of perception Next Generation Pharmaceutical (Europe)             • Supply chain optimisation Next Generation Pharmaceutical (Europe)             • Translational medicine paradigm: hip or hype? Next Generation Pharmaceutical (US)             • The evolution of drug safety Next Generation Pharmaceutical (US)             • Investigating cell death resistance in tumor cells Next Generation Pharmaceutical (US)             • A culture of engagement and inclusion Next Generation Pharmaceutical (US)             • Leading Lilly forward Next Generation Pharmaceutical (US)
SELECTED ISSUE
COVER: Next Generation Pharmaceutical 12

Sponsors

PAST ISSUES
Issue 12, March 2008 Issue 11, December 2007
Issue 10, October 2007 Issue 9, July 2007
Issue 8, April 2007 Issue 7, December 2006
Issue 6, August 2006 Issue 5, April 2006
Issue 4, December 2005 Issue 3, August 2005
Issue 2, May 2005 Issue 1, November 2004

LEAD STORIES

Leading Lilly forward
John Lechleiter, newly appointed CEO of Eli Lilly, addresses Lilly’s stance in the industry and reveals the directions in which he’ll be taking the company after stepping into the leadership role on April 1. By Leslie Knudson

• The importance of operations
• The new risk management paradigm
• All articles from "LEAD STORIES" section		 Companies in this issue

BUSINESS STRATEGIES / IT

• Moving beyond rote case reporting: demonstrating a believable commitment to patient safety
• The evolution of drug safety
• Web based CRO: cardiocore delivers with VisualVault
• The outsourcing advantage

CLINICAL RESEARCH / TRIALS

• Optimizing clinical protocol development to enhance research productivity
• A new frontier for clinical trials
• Clinical research in South Africa
• 4plex, real-time one-step RT-PCR without optimization
• View from 37,000 feet – weathering change in the Pharmaceutical Industry
• Improving treatment for diabetes
• Speeding up clinical trials
• Indipharm: your gateway to clinical trials in India
• Coping successfully with changing regulations in Experimental Clinical Pharmacology (Phase I)
• Unmasking the blind of over-capsulation
• Almac’s new North American headquarters
• Concepts underlining change in the clinical research field
• Averion International Corp.
• The commercialization of companion diagnostics
• Performance benchmarks
• Translational medicine paradigm: hip or hype?
• Biotherapeutics: the way of the future?
• Fighting heart disease

DRUG DISCOVERY

• Standardizing blood collection
• PRF&L (Pocono Rabbit Farm and Laboratory) – the Custom Antibody company
• Quanta BioSciences introduces next generation qPCR and qRT-PCR reagents for genomic and gene expression applications
• Improved productivity and throughput in qPCR without compromising performance
• Making the most of your knowledge
• Novel tools for the science of change – refining epigenetic research
• The Top 3 Grid Application Areas for Pharma R&D: Drug Discovery, Clinical Analysis and Data Management
• Changing the definition of productivity and performance
• Transitioning existing LC methods to new technologies
• Expanding into Biotherapeutics
• Success story: Novartis
• On the horizon
• Electronic Lab Notebooks: improve efficiency by spending less time on paperwork and more time on R&D
• The science and ethics of good communication
• The iuvo Microconduit Array (MCA)
• Roche Diagnostics
• BioMicro Systems – optimizing Microarray results with the MAUI product line
• Pharma-diagnostics outsourcing alliances for personalized medicine
• Cisbio and HTRF®: leadership in assay development and services for drug discovery
• Accelerating drug development
• The right connection
• Strategic partnering to address the challenges facing pharma
• A cure for the pharma R&D blues
• Neowater®: a cure for the pharma “R&D blues”
• IUVO
• Investigating cell death resistance in tumor cells
• Simplifying science
• Bone builders

LEAD STORIES

• Big in Germany
• Looking to the future
• Navigating the turbulent path to sustainability
• Leading Lilly forward
• The importance of operations
• The new risk management paradigm

MANUFACTURING

• Ensuring global compliance
• The importance of the supply chain
• Performance Validation, LLC Next Generation Pharmaceuticals

MARKETING

• Successful KOL management
• Corporate Integrity Agreements: making them work for you
• Patient-doctor communications
• The prescription for KOL Management
• Building successful strategies to drive reimbursement and access
• The power of perception
• Making the best of a tough situation
• The importance of marketing

STAFFING

• The war for talent
• A culture of engagement and inclusion
• Scientific careers, staffing solutions for impending retirement of baby boomers